Your browser doesn't support javascript.
loading
Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study.
Takeshita, Akihiro; Asou, Norio; Atsuta, Yoshiko; Sakura, Toru; Ueda, Yasunori; Sawa, Masashi; Dobashi, Nobuaki; Taniguchi, Yasuhiro; Suzuki, Rikio; Nakagawa, Masaru; Tamaki, Shigehisa; Hagihara, Maki; Fujimaki, Katsumichi; Furumaki, Hiroaki; Obata, Yukako; Fujita, Hiroyuki; Yanada, Masamitsu; Maeda, Yoshinobu; Usui, Noriko; Kobayashi, Yukio; Kiyoi, Hitoshi; Ohtake, Shigeki; Matsumura, Itaru; Naoe, Tomoki; Miyazaki, Yasushi.
Afiliação
  • Takeshita A; Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashiku, Hamamatsu, 431-3192, Japan. akihirot@hama-med.ac.jp.
  • Asou N; International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka, 350-1298, Japan.
  • Atsuta Y; The Japanese Data Center for Hematopoietic Cell Transplantation, 1-1-20 Taikou-minami, Higashiku, Nagoya, 461-0047, Japan.
  • Sakura T; Hematology, Saiseikai Maebashi Hospital, 564-1 Kamishindenmachi, Maebashi, 371-0821, Japan.
  • Ueda Y; Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, 710-8602, Japan.
  • Sawa M; Hematology and Oncology, Anjo Kosei Hospital, 28 Higashikurokute, Anjochou, Anjo, 446-8602, Japan.
  • Dobashi N; Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-19-18 Nishisinbashi, Minatoku, Tokyo, 105-8471, Japan.
  • Taniguchi Y; Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Ohsakasayama, 589-8511, Japan.
  • Suzuki R; Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isahara, 259-1193, Japan.
  • Nakagawa M; Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Ohyaguchi Kamichou, Itabashiku, Tokyo, 173-8610, Japan.
  • Tamaki S; Hematology, Japanese Red Cross Ise Hospital, 1-471-2 Funae, Ise, 516-8512, Japan.
  • Hagihara M; Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawaku, Yokohama, 236-0004, Japan.
  • Fujimaki K; Hematology, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa, 251-8550, Japan.
  • Furumaki H; Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashiku, Hamamatsu, 431-3192, Japan.
  • Obata Y; Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashiku, Hamamatsu, 431-3192, Japan.
  • Fujita H; Hematology, Saiseikai Yokohama Nanbu Hospital, 3-2-10 Kounandai, Kounanku, Yokohama, 234-0054, Japan.
  • Yanada M; Hematology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake, 470-1192, Japan.
  • Maeda Y; Hematology, Oncology and Respiratory Medicine, Okayama University Medical School, 2-5-1 Shikatachou, Kitaku, Okayama, 700-8558, Japan.
  • Usui N; Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-19-18 Nishisinbashi, Minatoku, Tokyo, 105-8471, Japan.
  • Kobayashi Y; National Cancer Center Hospital, 5-1-1 Tsukiji, Chuouku, Tokyo, 104-0045, Japan.
  • Kiyoi H; Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumaichou, Showaku, Nagoya, 466-8550, Japan.
  • Ohtake S; Kanazawa University, Kakumamachi, Kanazawa, 920-1192, Japan.
  • Matsumura I; Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Ohsakasayama, 589-8511, Japan.
  • Naoe T; National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Nakaku, Nagoya, 460-0001, Japan.
  • Miyazaki Y; Hematology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Leukemia ; 33(2): 358-370, 2019 02.
Article em En | MEDLINE | ID: mdl-30093681

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetra-Hidronaftalenos / Benzoatos / Leucemia Promielocítica Aguda / Terapia de Salvação / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetra-Hidronaftalenos / Benzoatos / Leucemia Promielocítica Aguda / Terapia de Salvação / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido